I would love to see the juicy stuff . Would you care to share ?
- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene highly effective in Melanoma preclinical study
Ann: Zantrene highly effective in Melanoma preclinical study, page-174
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M |
Open | High | Low | Value | Volume |
$1.48 | $1.49 | $1.47 | $34.83K | 23.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5616 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.48 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5616 | 1.460 |
2 | 20859 | 1.455 |
3 | 46800 | 1.450 |
2 | 25548 | 1.440 |
1 | 2046 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.480 | 500 | 1 |
1.490 | 3770 | 2 |
1.530 | 12667 | 2 |
1.535 | 2285 | 1 |
1.570 | 37690 | 1 |
Last trade - 10.41am 13/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online